Literature DB >> 22345473

Efficient Nef-mediated downmodulation of TCR-CD3 and CD28 is associated with high CD4+ T cell counts in viremic HIV-2 infection.

Mohammad Khalid1, Hangxing Yu, Daniel Sauter, Shariq M Usmani, Jan Schmokel, Jerome Feldman, Rob A Gruters, Marchina E van der Ende, Matthias Geyer, Sarah Rowland-Jones, Albert D Osterhaus, Frank Kirchhoff.   

Abstract

The role of the multifunctional accessory Nef protein in the immunopathogenesis of HIV-2 infection is currently poorly understood. Here, we performed comprehensive functional analyses of 50 nef genes from 21 viremic (plasma viral load, >500 copies/ml) and 16 nonviremic (<500) HIV-2-infected individuals. On average, nef alleles from both groups were equally active in modulating CD4, TCR-CD3, CD28, MHC-I, and Ii cell surface expression and in enhancing virion infectivity. Thus, many HIV-2-infected individuals efficiently control the virus in spite of efficient Nef function. However, the potency of nef alleles in downmodulating TCR-CD3 and CD28 to suppress the activation and apoptosis of T cells correlated with high numbers of CD4(+) T cells in viremic patients. No such correlations were observed in HIV-2-infected individuals with undetectable viral load. Further functional analyses showed that the Nef-mediated downmodulation of TCR-CD3 suppressed the induction of Fas, Fas-L, PD-1, and CTLA-4 cell surface expression as well as the secretion of gamma interferon (IFN-γ) by primary CD4(+) T cells. Moreover, we identified a single naturally occurring amino acid variation (I132T) in the core domain of HIV-2 Nef that selectively disrupts its ability to downmodulate TCR-CD3 and results in functional properties highly reminiscent of HIV-1 Nef proteins. Taken together, our data suggest that the efficient Nef-mediated downmodulation of TCR-CD3 and CD28 help viremic HIV-2-infected individuals to maintain normal CD4(+) T cell homeostasis by preventing T cell activation and by suppressing the induction of death receptors that may affect the functionality and survival of both virally infected and uninfected bystander cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22345473      PMCID: PMC3347365          DOI: 10.1128/JVI.06856-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Mechanism for down-regulation of CD28 by Nef.

Authors:  T Swigut; N Shohdy; J Skowronski
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

Review 2.  Structure--function relationships in HIV-1 Nef.

Authors:  M Geyer; O T Fackler; B M Peterlin
Journal:  EMBO Rep       Date:  2001-07       Impact factor: 8.807

3.  HIV-1 Nef impairs MHC class II antigen presentation and surface expression.

Authors:  P Stumptner-Cuvelette; S Morchoisne; M Dugast; S Le Gall; G Raposo; O Schwartz; P Benaroch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

4.  Simian and human immunodeficiency virus Nef proteins use different surfaces to downregulate class I major histocompatibility complex antigen expression.

Authors:  T Swigut; A J Iafrate; J Muench; F Kirchhoff; J Skowronski
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

5.  HIV-1 Nef disrupts intracellular trafficking of major histocompatibility complex class I, CD4, CD8, and CD28 by distinct pathways that share common elements.

Authors:  Jolie A Leonard; Tracy Filzen; Christoph C Carter; Malinda Schaefer; Kathleen L Collins
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

Review 6.  AIDS as a zoonosis: scientific and public health implications.

Authors:  B H Hahn; G M Shaw; K M De Cock; P M Sharp
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

7.  The conserved process of TCR/CD3 complex down-modulation by SIV Nef is mediated by the central core, not endocytic motifs.

Authors:  Todd M Schaefer; Ian Bell; Melanie E Pfeifer; Mimi Ghosh; Ronald P Trible; Craig L Fuller; Claire Ashman; Todd A Reinhart
Journal:  Virology       Date:  2002-10-10       Impact factor: 3.616

8.  Antiviral resistance of biologic HIV-2 clones obtained from individuals on nucleoside reverse transcriptase inhibitor therapy.

Authors:  M E van der Ende; C Guillon; P H Boers; T D Ly; R A Gruters; A D Osterhaus; M Schutten
Journal:  J Acquir Immune Defic Syndr       Date:  2000-09-01       Impact factor: 3.731

9.  Lower HIV-2 plasma viral loads may explain differences between the natural histories of HIV-1 and HIV-2 infections.

Authors:  V Shanmugam; W M Switzer; J N Nkengasong; G García-Lerma; T A Green; E Ekpini; M Sassan-Morokro; F Antunes; K Manshino; V Soriano; S Z Wiktor; W Heneine
Journal:  J Acquir Immune Defic Syndr       Date:  2000-07-01       Impact factor: 3.731

10.  Efficient class I major histocompatibility complex down-regulation by simian immunodeficiency virus Nef is associated with a strong selective advantage in infected rhesus macaques.

Authors:  J Münch; N Stolte; D Fuchs; C Stahl-Hennig; F Kirchhoff
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more
  20 in total

1.  HLA-DQB1*06 and breadth of Nef core region-specific T-cell response are associated with slow disease progression in antiretroviral therapy-naive Chinese HIV-1 subtype B patients.

Authors:  Weihua Li; Chuanyun Li; Wei Xia; Xiuhui Li
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

2.  Maintenance of AP-2-Dependent Functional Activities of Nef Restricts Pathways of Immune Escape from CD8 T Lymphocyte Responses.

Authors:  Blake Schouest; Andrea M Weiler; Sanath Kumar Janaka; Tereance A Myers; Arpita Das; Sarah C Wilder; Jessica Furlott; Melody Baddoo; Erik K Flemington; Eva G Rakasz; David T Evans; Thomas C Friedrich; Nicholas J Maness
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

3.  HIV-2 Depletes CD4 T Cells through Pyroptosis despite Vpx-Dependent Degradation of SAMHD1.

Authors:  Xiaoyu Luo; Eytan Herzig; Gilad Doitsh; Zachary W Grimmett; Isa Muñoz-Arias; Warner C Greene
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

Review 4.  How HIV Nef Proteins Hijack Membrane Traffic To Promote Infection.

Authors:  Cosmo Z Buffalo; Yuichiro Iwamoto; James H Hurley; Xuefeng Ren
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

5.  Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2.

Authors:  Elena Heusinger; Katja Deppe; Paola Sette; Christian Krapp; Dorota Kmiec; Silvia F Kluge; Preston A Marx; Cristian Apetrei; Frank Kirchhoff; Daniel Sauter
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

6.  Lentiviral Nef proteins manipulate T cells in a subset-specific manner.

Authors:  Hangxing Yu; Mohammad Khalid; Anke Heigele; Jan Schmökel; Shariq M Usmani; Johannes van der Merwe; Jan Münch; Guido Silvestri; Frank Kirchhoff
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

7.  Acute Viral Escape Selectively Impairs Nef-Mediated Major Histocompatibility Complex Class I Downmodulation and Increases Susceptibility to Antiviral T Cells.

Authors:  Andrea M Weiler; Arpita Das; Oluwasayo Akinyosoye; Sherry Cui; Shelby L O'Connor; Elizabeth A Scheef; Jason S Reed; Antonito T Panganiban; Jonah B Sacha; Eva G Rakasz; Thomas C Friedrich; Nicholas J Maness
Journal:  J Virol       Date:  2015-12-04       Impact factor: 5.103

8.  HIV-1 Nef and T-cell activation: a history of contradictions.

Authors:  Tristan J Markle; Mwimanzi Philip; Mark A Brockman
Journal:  Future Virol       Date:  2013-04-01       Impact factor: 1.831

9.  Selective Disruption of SERINC5 Antagonism by Nef Impairs SIV Replication in Primary CD4+ T Cells.

Authors:  Sanath Kumar Janaka; Alexandra V Palumbo; Aidin Tavakoli-Tameh; David T Evans
Journal:  J Virol       Date:  2021-01-27       Impact factor: 5.103

10.  The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals.

Authors:  Hangxing Yu; Shariq M Usmani; Alexandra Borch; Julia Krämer; Christina M Stürzel; Mohammad Khalid; Xuehua Li; Daniela Krnavek; Marchina E van der Ende; Albert D Osterhaus; Rob A Gruters; Frank Kirchhoff
Journal:  Retrovirology       Date:  2013-03-05       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.